Patrick Fahr

Dr Patrick Fahr is a senior health economist at the Nuffield Department of Primary Care health Sciences.

Patrick started his research career as a doctoral research student reading for a DPhil in Health Economics at the Nuffield Department of Population Health, University of Oxford. His thesis explored the challenges of using biomedical big data for health economic analyses in the context of rare genetic diseases and genome-based diagnostic technologies, working within Genomic England's 100,000 Genomes Project.

After finishing his DPhil, Patrick joined the Nuffield Department of Primary Care Health Sciences to lead the health economics work on the Oxford Martin Future of Cooling Programme. This ongoing work focuses on the impact of suboptimal temperature exposure on healthcare resource utilisation and associated costs, using observational data for econometric analyses.

In addition, Patrick is working on multiple other projects. He is co-leading the economics work on a larger vaccine impact assessment modelling study funded by the Coalition for Epidemic Preparedness Innovations (CEPI), investigating the impact of CEPI's investments in Lassa fever and Chikungunya globally, in terms of infection, disease and economic impact. He is also co-leading a cost-benefit analysis on the Welsh Basic Income Pilot for Care Leavers, a cost-effectiveness study on weight loss interventions supported by the Novo Nordisk Foundation, and a cost-effectiveness study on deprescribing blood pressure drugs in older people. Last, Patrick has recently been awarded an NIHR Global Health Transformation grant as a co-investigator leading the economics work on a project that will investigate novel extreme weather risk insurance systems in Kenya.

Being a member of both the Medical Statistics Group and the Health Economics and Policy Group, Patrick is also engaged in teaching across the various graduate programmes offered by the Department. He also acts as a college advisor at Kellogg College.

Last, Patrick has acted as a consultant for various organisations, including Genomics England, the United Nations, the Inter-American Development Bank, and the World Bank Group.

Research focus

Health technology assessment

Economic evaluations

Econometric analysis

Regulatory affairs

Real world data analysis

Health Impacts of Climate Change

Global Health